Search Results

Swine flu vaccines: baseline rates of possible AEs estimated

Source: Reactions, Volume 1, Number 1277, 2009-11-07 , pp. 1-1(1)

Publisher: Adis International

Oral hormonal contraceptives containing drospirenone have a comparative safety profile to that of other preparations currently available

Source: Reactions, Volume 1, Number 1277, 2009-11-07 , pp. 3-3(1)

Publisher: Adis International

Byetta label changed to include renal failure warnings

Source: Reactions, Volume 1, Number 1277, 2009-11-07 , pp. 5-5(1)

Publisher: Adis International

Safety profiles for oseltamivir and zanamivir remain positive

Source: Reactions, Volume 1, Number 1278, 2009-11-14 , pp. 2-2(1)

Publisher: Adis International

Nebulisers not an option with Relenza dry powder

Source: Reactions, Volume 1, Number 1278, 2009-11-14 , pp. 2-2(1)

Publisher: Adis International

Bisphosphonates and the risk of ONJ

Source: Reactions, Volume 1, Number 1278, 2009-11-14 , pp. 3-3(1)

Publisher: Adis International

New vaccine safety surveillance tool free for some countries

Source: Reactions, Volume 1, Number 1274, 2009-10-17 , pp. 2-2(1)

Publisher: Adis International

Medication incident over dual brandnames for sildenafil

Source: Reactions, Volume 1, Number 1275, 2009-10-24 , pp. 2-2(1)

Publisher: Adis International

IVIG haemolysis risk highlighted in Canada

Source: Reactions, Volume 1, Number 1275, 2009-10-24 , pp. 2-2(1)

Publisher: Adis International

MHRA announce safety monitoring programme for swine flu vaccines

Source: Reactions, Volume 1, Number 1276, 2009-10-31 , pp. 4-4(1)

Publisher: Adis International

ADR reports from consumers tend to have more information than those submitted by healthcare professionals;

Source: Reactions, Volume 1, Number 1270, 2009-09-19 , pp. 2-2(1)

Publisher: Adis International

Improved reporting of drug incidents in NHS

Source: Reactions, Volume 1, Number 1270, 2009-09-19 , pp. 4-4(1)

Publisher: Adis International

Currently, the US FDA is not requiring changes to the prescribing information of Tysabri [natalizumab] or to the risk management plan

Source: Reactions, Volume 1, Number 1271, 2009-09-26 , pp. 2-2(1)

Publisher: Adis International

Warning regarding potential dosing errors with Tamiflu

Source: Reactions, Volume 1, Number 1272, 2009-10-03 , pp. 2-2(1)

Publisher: Adis International

Evidence linking Lantus to higher cancer risk inconclusive − Medsafe

Source: Reactions, Volume 1, Number 1272, 2009-10-03 , pp. 3-3(1)

Publisher: Adis International

A batch of the human papillomavirus (HPV) vaccine Cervarix is being voluntarily recalled in the UK following the death of a 14-year-old girl.

Source: Reactions, Volume 1, Number 1272, 2009-10-03 , pp. 3-3(1)

Publisher: Adis International

US FDA lays out strategy for risk communication

Source: Reactions, Volume 1, Number 1273, 2009-10-10 , pp. 2-2(1)

Publisher: Adis International

Revised heparin USP monograph will decrease its potency

Source: Reactions, Volume 1, Number 1273, 2009-10-10 , pp. 2-2(1)

Publisher: Adis International

UK health officials have determined that it was unlikely that Cervarix was the cause of death in a 14-year-old girl.

Source: Reactions, Volume 1, Number 1273, 2009-10-10 , pp. 3-3(1)

Publisher: Adis International

ADRAC reports on metoclopramide and movement disorders

Source: Reactions, Volume 1, Number 1273, 2009-10-10 , pp. 3-3(1)

Publisher: Adis International